Vivos Therapeutics, Inc. (VVOS) stock is falling to 9.61% in aftermarket – Recent news to know
Vivos Therapeutics, Inc. (VVOS) experienced a decline of 9.61% in the aftermarket following the announcement of the company’s participation at the Benzinga Global Small Cap Conference. However, the last trading session concluded at $2.29 with a decrease of 8.03%. Benzinga Global Small-Cap Conference – What’s up? VVOS announced on 3rd December 2021 that the company’s […]
